Low-Coordinate Magnesium Sulfide and Selenide Complexes

Facile, Reversible Hydrogen Activation by Low-Coordinate Magnesium Oxide Complexes

New approaches to achieve facile and reversible dihydrogen activation are of importance for synthesis, catalysis, and hydrogen storage. Here we show that low-coordinate magnesium oxide complexes [{(RDipnacnac)Mg}2(μ-O)] 1, with RDipnacnac = HC(RCNDip)2, Dip = 2,6-iPr2C6H3, R = Me (1a), Et (1b), iPr (1c), readily react with dihydrogen under mild conditions to afford mixed hydride-hydroxide complexes [{(RDipnacnac)Mg}2(μ-H)(μ-OH)] 4. Dehydrogenation of complexes 4 is strongly dependent on remote ligand substitution and can be achieved by simple vacuum-degassing of 4c (R = iPr) to regain 1c. Donor addition to complexes 4 also releases hydrogen and affords donor adducts of magnesium oxide complexes. Computational studies suggest that the hydrogen activation mechanism involves nucleophilic attack of an oxide lone pair at a weakly bound H2···Mg complex in an SN2-like manner that induces a heterolytic dihydrogen cleavage to yield an MgOH and an MgH unit. Alternative synthetic routes into complex 4b from a magnesium hydride complex have been investigated and the ability of complexes 1 or 4 to act as catalysts for the hydrogenation of 1,1-diphenylethene (DPE) has been tested.

Transdermal Hydrogen Sulfide Delivery Enabled by Open-Metal-Site Metal-Organic Frameworks

Hydrogen sulfide (H2S) is an endogenously produced gasotransmitter involved in many physiological processes that are integral to proper cellular functioning. Due to its profound anti-inflammatory and antioxidant properties, H2S plays important roles in preventing inflammatory skin disorders and improving wound healing. Transdermal H2S delivery is a therapeutically viable option for the management of such disorders. However, current small-molecule H2S donors are not optimally suited for transdermal delivery and typically generate electrophilic byproducts that may lead to undesired toxicity. Here, we demonstrate that H2S release from metal-organic frameworks (MOFs) bearing coordinatively unsaturated metal centers is a promising alternative for controlled transdermal delivery of H2S. Gas sorption measurements and powder X-ray diffraction (PXRD) studies of 11 MOFs support that the Mg-based framework Mg2(dobdc) (dobdc4- = 2,5-dioxidobenzene-1,4-dicarboxylate) is uniquely well-suited for transdermal H2S delivery due to its strong yet reversible binding of H2S, high capacity (14.7 mmol/g at 1 bar and 25 °C), and lack of toxicity. In addition, Rietveld refinement of synchrotron PXRD data from H2S-dosed Mg2(dobdc) supports that the high H2S capacity of this framework arises due to the presence of three distinct binding sites. Last, we demonstrate that transdermal delivery of H2S from Mg2(dobdc) is sustained over a 24 h period through porcine skin. Not only is this significantly longer than sodium sulfide but this represents the first example of controlled transdermal delivery of pure H2S gas. Overall, H2S-loaded Mg2(dobdc) is an easily accessible, solid-state source of H2S, enabling safe storage and transdermal delivery of this therapeutically relevant gas.

Beyond Triphenylphosphine: Advances on the Utilization of Triphenylphosphine Oxide

Triphenylphosphine oxide is a well-known industrial waste byproduct, and thousands of tons of it are generated every year. Due to its chemical stability and limited applications, settlement of this waste issue has drawn extensive attention from chemists. The reduction of triphenylphosphine oxide to triphenylphosphine is heretofore the most employed solution, and is well reviewed. In view of our recent studies on the selective and efficient conversion of Ph3P(O) to other valuable organophosphorus chemicals by using sodium, the present perspective mainly highlights the advances on the utilization of Ph3P(O) to prepare a diverse range of functional organophosphorus compounds, except Ph3P, via selective P-C, C-H, and P-O bond cleavages.